10-K · February 19, 2026
IDEX describes a strategy focused on niche, mission-critical engineered products, organic growth and strategic acquisitions (e.g., Micro-LAM acquired July 2025) and emphasizes decentralized operating units united by…
Earnings analysis · 10-Q
Filed April 29, 2026 · Our reading of the company's report
The latest report
IDEX Corporation reported strong financial results for Q1 2026, with revenues of $886.9 million surpassing expectations and up 9% year-over-year. Adjusted EPS also increased to $2.00, marking a 14% rise from Q1 2025.…
IDEX Corporation reported strong financial results for Q1 2026, with revenues of $886.9 million surpassing expectations and up 9% year-over-year. Adjusted EPS also increased to $2.00, marking a 14% rise from Q1 2025. Segment growth was driven primarily by the Health & Science Technologies sector, while the Fluid & Metering segment saw modest growth, and the Fire & Safety segment experienced a slight decline.
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
Where each $100 of revenue went in this report.
Cost of sales, operating expenses, and what remained. Figures are rounded to whole dollars.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Revenue reached $886.9 million, up 9% from $814.3 million in the prior year.
Adjusted EPS of $2.00 surpassed estimates and increased 14% compared to $1.75 in Q1 2025.
Health & Science Technologies grew 17%, driven by strength in data centers and semiconductors.
Gross margin stood at 44.9%, slightly down by 40 bps from the prior year, but operating income grew 21%.
Free cash flow was reported at $86.0 million despite a slight decline year-over-year.
Returned $129.1 million to shareholders through repurchases and dividends.
Fire & Safety/Diversified Products segment declined 2%, with lower volumes affecting growth.
Gross margin decreased to 44.9% from 45.3%, affected by unfavorable product mix.
Ongoing changes in tariffs following recent Supreme Court rulings could impact costs.
Outlook deferred to earnings press release / call.
IDEX describes a strategy focused on niche, mission-critical engineered products, organic growth and strategic acquisitions (e.g., Micro-LAM acquired July 2025) and emphasizes decentralized operating units united by…
IDEX reported third-quarter net sales of $878.7 million and diluted EPS of $1.70 for the three months ended September 30, 2025. Revenue and segment Adjusted EBITDA were higher year-over-year (net sales up from $798.2M;…
IDEX presents a diversified, niche-industrial strategy organized into three reportable segments (FMT, HST, FSDP) focused on organic growth plus strategic acquisitions. The 2024 10‑K highlights a roughly even…
IDEX reported third-quarter net sales of $798.2 million (up $4.8 million vs. Q3 2023) with gross profit of $353.9 million and diluted EPS of $1.57, down from $2.75 a year ago. Operating income declined to $168.0 million…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.